McKesson Comprehensive Income 2010-2024 | MCK
McKesson comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- McKesson comprehensive income for the quarter ending September 30, 2024 was $-0.890B, a 0.34% increase year-over-year.
- McKesson comprehensive income for 2024 was $-0.881B, a 2.65% decline from 2023.
- McKesson comprehensive income for 2023 was $-0.905B, a 41% decline from 2022.
- McKesson comprehensive income for 2022 was $-1.534B, a 3.65% increase from 2021.
McKesson Annual Comprehensive Income
(Millions of US $) |
| 2024 |
$-881 |
| 2023 |
$-905 |
| 2022 |
$-1,534 |
| 2021 |
$-1,480 |
| 2020 |
$-1,703 |
| 2019 |
$-1,849 |
| 2018 |
$-1,717 |
| 2017 |
$-2,141 |
| 2016 |
$-1,561 |
| 2015 |
$-1,713 |
| 2014 |
$-3 |
| 2013 |
$-65 |
| 2012 |
$5 |
| 2011 |
$87 |
| 2010 |
$6 |
| 2009 |
$-179 |
McKesson Quarterly Comprehensive Income
(Millions of US $) |
| 2024-09-30 |
$-890 |
| 2024-06-30 |
$-913 |
| 2024-03-31 |
$-881 |
| 2023-12-31 |
$-812 |
| 2023-09-30 |
$-887 |
| 2023-06-30 |
$-848 |
| 2023-03-31 |
$-905 |
| 2022-12-31 |
$-899 |
| 2022-09-30 |
$-1,114 |
| 2022-06-30 |
$-948 |
| 2022-03-31 |
$-1,534 |
| 2021-12-31 |
$-1,655 |
| 2021-09-30 |
$-1,665 |
| 2021-06-30 |
$-1,627 |
| 2021-03-31 |
$-1,480 |
| 2020-12-31 |
$-1,503 |
| 2020-09-30 |
$-1,597 |
| 2020-06-30 |
$-1,735 |
| 2020-03-31 |
$-1,703 |
| 2019-12-31 |
$-1,663 |
| 2019-09-30 |
$-1,704 |
| 2019-06-30 |
$-1,778 |
| 2019-03-31 |
$-1,849 |
| 2018-12-31 |
$-1,826 |
| 2018-09-30 |
$-1,762 |
| 2018-06-30 |
$-1,801 |
| 2018-03-31 |
$-1,717 |
| 2017-12-31 |
$-1,726 |
| 2017-09-30 |
$-1,710 |
| 2017-06-30 |
$-1,936 |
| 2017-03-31 |
$-2,141 |
| 2016-12-31 |
$-2,228 |
| 2016-09-30 |
$-1,854 |
| 2016-06-30 |
$-1,739 |
| 2016-03-31 |
$-1,561 |
| 2015-12-31 |
$-1,845 |
| 2015-09-30 |
$-1,644 |
| 2015-06-30 |
$-1,434 |
| 2015-03-31 |
$-1,713 |
| 2014-12-31 |
$-804 |
| 2014-09-30 |
$-425 |
| 2014-06-30 |
$107 |
| 2014-03-31 |
$-3 |
| 2013-12-31 |
$-68 |
| 2013-09-30 |
$-16 |
| 2013-06-30 |
$-118 |
| 2013-03-31 |
$-65 |
| 2012-12-31 |
$35 |
| 2012-09-30 |
$46 |
| 2012-06-30 |
$-30 |
| 2012-03-31 |
$5 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$-21 |
| 2011-06-30 |
$103 |
| 2011-03-31 |
$87 |
| 2010-12-31 |
$51 |
| 2010-09-30 |
$-2 |
| 2010-06-30 |
$-51 |
| 2010-03-31 |
$6 |
| 2009-12-31 |
$23 |
| 2009-09-30 |
$3 |
| 2009-06-30 |
$-84 |
| 2009-03-31 |
$-179 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$79.753B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
